30-Day Readmissions and Coordination of Care Following Endoscopic Transsphenoidal Pituitary Surgery: Experience with 409 Patients

Author:

Ghiam Michael K.1,Chyou Darius E.2,Dable Cortney L.2,Katz Andrew P.1,Eichberg Daniel G.3,Zhang Hang4,Ayala Alejandro R.5,Kargi Atil Y.5,Komotar Ricardo J.3,Sargi Zoukaa6

Affiliation:

1. Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States

2. University of Miami Miller School of Medicine, Miami, Florida, United States

3. Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, United States

4. Division of Biostatistics, Department of Public Health Sciences, University of Miami, Miami, Florida, United States

5. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States

6. Department of Otolaryngology, Head and Neck Surgery, Sylvester Comprehensive Cancer Center, Jackson Memorial Hospital/University of Miami Miller School of Medicine, Miami, Florida, United States

Abstract

Abstract Objective The study aimed to (1) quantify readmission rates and common causes of readmission following endoscopic transsphenoidal pituitary surgery (ETPS); (2) identify risk factors that may predict readmission within 30 days; (3) assess postoperative care coordination with endocrinology follow-up; and (4) identify patients for whom targeted interventions may reduce 30-day readmissions. Methods Retrospective quality improvement review of patients with pituitary adenoma who underwent ETPS from December 2010 to 2018 at a single tertiary care center. Results A total of 409 patients were included in the study, of which 57 (13.9%) were readmitted within 30 days. Hyponatremia was the most common cause of readmission (4.2%) followed by pain/headache (3.9%), cerebrospinal fluid leak (3.4%), epistaxis (2.7%), hypernatremia (1.2%), and adrenal insufficiency (1.2%). Patients with hyponatremia were readmitted significantly earlier than other causes (4.3 ± 2.2 vs. 10.6 ± 10.9 days from discharge, p = 0.032). Readmitted patients had significantly less frequent outpatient follow-up with an endocrinologist than the nonreadmitted cohort (56.1 vs. 70.5%, p = 0.031). Patients who had outpatient follow-up with an endocrinologist were at lower risk of readmission compared with those without (odds ratio: 0.46; 95% confidence interval: 0.24–0.88). Conclusion Delayed hyponatremia is one of the most common causes of 30-day readmission following ETPS. Postoperative follow-up with an endocrinologist may reduce risk of 30-day readmission following ETPS. Implications for Clinical Practice A multidisciplinary team incorporating otolaryngologist, neurosurgeons, and endocrinologist may identify patients at risk of 30-day readmissions. Protocols checking serum sodium within 1 week of surgery in conjunction with endocrinologist to tailor fluid restriction may reduce readmissions from delayed hyponatremia.

Publisher

Georg Thieme Verlag KG

Subject

Neurology (clinical)

Reference36 articles.

1. Significant increases of pituitary tumors and resections from 1993 to 2011;J A Villwock;Int Forum Allergy Rhinol,2014

2. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009;H Gittleman;J Neurosurg,2014

3. The role of endoscopic endonasal approach in the multimodal management of giant pituitary adenoma: case report and literature review;S Chibbaro;Asian J Neurosurg,2018

4. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients;J A Gondim;Pituitary,2011

5. Endoscopic endonasal surgery for treatment of pituitary apoplexy: 16 years of experience in a specialized pituitary center;J A Gondim;World Neurosurg,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3